Associated Syndromes with Dieulafoy Lesions
Dieulafoy lesions are not typically associated with specific genetic or familial syndromes, unlike other gastrointestinal lesions such as duodenal hamartomas which occur with Peutz-Jeghers, Cowden, and juvenile polyposis syndromes. 1
Key Clinical Associations
Advanced Liver Disease
- Patients with advanced liver disease (cirrhosis, portal hypertension, or infiltrative liver disease) have a significantly higher risk of Dieulafoy lesion-like bleeding compared to the general population (OR = 19.04; 95% CI 2.1-900.8; p < 0.002). 2
- This association is thought to be related to arteriolar spider nevi that develop in patients with liver disease, which can manifest as arterial-type bleeding in the upper gastrointestinal tract without mucosal ulceration. 2
Anticoagulation Use
- Nearly half of patients with Dieulafoy lesions are on anticoagulation medication at the time of presentation, though this represents a risk factor for bleeding rather than a syndromic association. 3
- Patients on antiplatelet therapy are significantly more likely to experience early rebleeding, making this the single most important predictor of recurrence. 4
Important Distinctions from Other Lesions
Not Associated with Familial Polyposis Syndromes
- Unlike duodenal hamartomas, which are typically associated with familial syndromes (Peutz-Jeghers, Cowden, juvenile polyposis), Dieulafoy lesions occur sporadically without genetic predisposition. 1
- Duodenal adenomas can arise with familial adenomatous polyposis (FAP) or MUTYH-associated polyposis, but Dieulafoy lesions do not share this association. 1
Clinical Context
Sporadic Nature
- Dieulafoy lesions are isolated vascular abnormalities consisting of tortuous, abnormally dilated submucosal arteries (1-3mm diameter) that penetrate through the gastrointestinal mucosa without an overlying ulcer. 4
- They account for 1-2% of acute gastrointestinal bleeding cases and carry a mortality rate of 10-17% if not promptly treated. 5
- The lesions occur more frequently in males and at younger ages than previously reported (average age 58 years). 3
Common Pitfall
- Do not confuse Dieulafoy lesions with syndromic gastrointestinal polyps or hamartomas—these are distinct pathologic entities with different underlying mechanisms and associations. 1